Processa Pharmaceuticals, Inc.
PCSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,850 | -$11,122 | -$27,424 | -$11,428 |
| Dep. & Amort. | $1 | $0 | $788 | $791 |
| Deferred Tax | $0 | $0 | $0 | -$531 |
| Stock-Based Comp. | $630 | $1,060 | $8,829 | $3,408 |
| Change in WC | -$112 | $605 | $544 | -$1,179 |
| Other Non-Cash | $87 | $1,392 | $7,658 | $221 |
| Operating Cash Flow | -$11,245 | -$8,063 | -$9,605 | -$8,717 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$3 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3 | -$3 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | $0 | $0 | $0 |
| Stock Issued | $7,763 | $6,321 | $0 | $10,050 |
| Stock Repurch. | -$16 | $0 | -$389 | -$64 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9 | -$53 | -$89 | -$186 |
| Financing Cash Flow | $7,733 | $6,269 | -$389 | $9,799 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,515 | -$1,797 | -$9,994 | $1,081 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,706 | $6,504 | $16,498 | $15,416 |
| End Cash | $1,191 | $4,706 | $6,504 | $16,498 |
| Free Cash Flow | -$11,248 | -$8,066 | -$9,605 | -$8,717 |